Abstract
Objective(s):
This study aimed to evaluate antibiotic resistance profiles and presence of virulence genes among Salmonella enterica serovar Enteritidis (S. Enteritidis) isolated from patients with gastroenteritis in various regions of Iran. Moreover, genetic relatedness among the strains was assessed by pulsed-field gel electrophoresis (PFGE).
Materials and Methods:
From April through September 2017, 59 Salmonella strains were isolated from 2116 stool samples. Of these strains, 27 S. Enteritidis were recovered. These strains were subjected to disk diffusion tests, polymerase chain reaction (PCR) for detection of virulence genes (invA, hilA, pefA, rck, stn, ssrA, ssaR, sefA, spvC, sipA, sipC, sopB, sopE, and sopE2), and PFGE.
Results:
High prevalence of resistance towards cefuroxime (n = 20, 74.1%) and ciprofloxacin (n = 13, 48.2%) were demonstrated. All tested strains possessed invA, hilA, sefA, sipA, sopB, and sopE. The least prevalent virulence gene was rck (n = 6; 22.2%). Based on combinations of virulence genes, 12 virulotypes were observed. The most common virulotype was VP2 (n = 12; 44.4%), harboring all of the virulence genes except for rck. PFGE typing showed only two distinct fingerprints among tested strains. Each fingerprint had completely different virulotypes. Notably, VP4 (harboring all genes except for rck and spvC) was only presented in pulsotype A, while VP2 was confined to pulsotype B.
Conclusion:
S. Enteritidis strains were derived from a limited number of clones, suggesting that it is highly homogenous. Future works should consider combinations of other genotyping methods together with larger sample sizes from more diverse sources.
Key Words: Antibiotic resistance, Gastroenteritis, PFGE, Salmonella enterica serotype – Enteritidis, Virulence genes
Introduction
Non-typhoidal Salmonella (NTS) serovars are among the most frequently reported causes of gastroenteritis across the globe, in particular in developing countries. It has been estimated that almost 94 million cases of gastroenteritis due to NTS occur annually, culminating in 155,000 deaths per year (1). Thus far, over 2,500 different Salmonella serovars have been identified. Nevertheless, Salmonella enterica serovar Enteritidis (S. Enteritidis) and S. enterica serovar Typhimurium still account for close to half of all human isolates of NTS (2). As a food-borne pathogen, S. Enteritidis has been associated with a variety of infectious diseases in different animals, including cattle, swine, and poultry. Contaminated animal products such as meat, pork, eggs, and milk are considered to be the main vehicle of transmission to humans (3).
The majority of Salmonella gastroenteritis cases are mild, self-limiting, and uncomplicated which seldom require antibiotic therapy. In addition, antibiotics do not diminish the duration of symptoms and may actually lengthen the period of asymptomatic shedding. However, they are reserved for patients with severe or invasive illnesses (4). On the other hand, injudicious and excessive use of antibiotics in livestock and poultry production is somewhat blamed for the emergence of multidrug-resistant (MDR) zoonotic pathogens, which may be transmitted from animals to humans through the food chain (5). Over the course of the past years, the world has witnessed a considerable upsurge in the prevalence of MDR Salmonella among patients. As a result, continuous surveillance and monitoring of antimicrobial resistance in foodborne pathogens will provide valuable data to healthcare professionals, researchers, and regulatory agencies (6-8).
Type 3 secretion systems (T3SS) play a prominent role in the pathogenesis of Salmonella. These syringe-like machines are specialized for the translocation of virulence determinants, also dubbed effector proteins, directly from the bacterial cytoplasm into host cells (9). In Salmonella, two functionally distinct T3SSs, which are encoded by Salmonella pathogenicity islands (SPIs), have hitherto been characterized. In this respect, T3SS encoded by SPI-1 delivers effector proteins required for intestinal invasion (10), while SPI-2 is activated intracellularly and is crucial for Salmonella replication inside host cells (11).
Over the recent years, there has been a significant rise in the number of salmonellosis cases in Iran. However, the majority of these cases were mostly reported from Tehran (12-16). There is a scarcity of data concerning the prevalence and characterization of clinical S. Enteritidis strains from other regions of Iran. Hence, the main objectives of the present study were to evaluate antibiotic resistance profiles and the presence of virulence genes among S. Enteritidis isolated from patients with gastroenteritis in various Iranian cities. In addition, we used pulsed-field gel electrophoresis (PFGE) to determine the clonal relatedness and to elucidate any epidemiological links between the S. Enteritidis strains.
Materials and Methods
Reagents and media
All of the common chemical reagents used in the current study were of analytical grade from commercial suppliers. Müeller-Hinton broth (MHB), Müeller-Hinton agar (MHA), triple sugar iron (TSI) agar, and tryptic soy broth (TSB) were procured from the Merck Co. (Darmstadt, Germany). Antibiotic disks were purchased from Mast Diagnostics Ltd. (Bootle, United Kingdom). Polyvalent and monospecific antisera against somatic and flagellar antigens were procured from BD DifcoTM (Franklin Lakes, NJ, USA). Ultrapure agarose gel powder was supplied from Invitrogen (Carlsbad, CA, USA). Restriction enzyme XbaI was obtained from Thermo Fisher Scientific (Waltham, MA, USA). The other materials and reagents were all obtained from Sigma Aldrich Co. (Steinheim, Germany).
Bacterial isolation
Bacterial strains were isolated from patients afflicted with gastroenteritis in four different cities (Figure 1) of Iran over the 6-month period of April to September, 2017. Patients could be enrolled if they had had >3 episodes of watery, loose, or bloody stools per day. Details were recorded of the age and gender of each patient from whom fecal samples were retrieved (Table 1). Strains were identified as S. Enteritidis using routine biochemical and serological assays (17). Briefly, the stool samples were transferred into Selenite-F broth and incubated at 37 °C for 8 hr. Then, the cultures were again sub-cultured on MacConkey agar. Suspected colonies were subjected to standard biochemical tests including oxidase, catalase, TSI agar, Methyl Red-Voges-Proskauer (MRVP), citrate consumption (Simmons citrate agar), and urease production. Further confirmation of the presumptive S. Enteritidis strains was performed by multiplex polymerase chain reaction (PCR) analysis, as described elsewhere (18). Stocks of all strains were stored frozen at -80 °C in cryovials containing TSB complemented with 20% (v/v) glycerol until required. Bacteria were recovered from freezing by transferring 100 µl into 5 mL of TSB, incubating overnight at 37 °C, and sub-culturing prior to use in assays.
Figure 1.
The locations of studied cities inside Iran. Numbers 1, 2, 3, 4, and 5 represent Tehran, Karaj, Semnan, Hamedan, and Yazd, respectively
Table 1.
Demographic profiles (age and gender distribution) of the patients together with city and date of isolation for each Salmonella enterica serovar Enteritidis strain
| Salmonella enterica serovar Enteritidis strain | Patients | |||
|---|---|---|---|---|
| ID | City | Date of isolation | Gender | Age |
| H1 | Hamedan | 4/14/2017 | Female | 11 |
| H2 | Hamedan | 5/10/2017 | Male | 3 |
| H3 | Hamedan | 6/5/2017 | Male | 62 |
| H4 | Hamedan | 7/23/2017 | Female | 27 |
| H5 | Hamedan | 7/26/2017 | Male | 61 |
| H6 | Hamedan | 8/31/2017 | Male | 54 |
| H7 | Hamedan | 9/5/2017 | Female | 5 |
| H8 | Hamedan | 9/17/2017 | Male | 19 |
| K1 | Karaj | 5/1/2017 | Female | 2 |
| K2 | Karaj | 6/26/2017 | Female | 71 |
| K3 | Karaj | 7/8/2017 | Female | 40 |
| K4 | Karaj | 8/28/2017 | Female | 39 |
| K5 | Karaj | 9/12/2017 | Female | 64 |
| K6 | Karaj | 9/23/2017 | Female | 13 |
| S1 | Semnan | 4/28/2017 | Male | 54 |
| S2 | Semnan | 5/1/2017 | Male | 9 |
| S3 | Semnan | 7/13/2017 | Female | 26 |
| S4 | Semnan | 8/4/2017 | Female | 48 |
| S5 | Semnan | 8/22/2017 | Male | 67 |
| S6 | Semnan | 9/15/2017 | Male | 4 |
| S7 | Semnan | 9/19/2017 | Male | 7 |
| Y1 | Yazd | 7/20/2017 | Female | 12 |
| Y2 | Yazd | 7/21/2017 | Male | 53 |
| Y3 | Yazd | 8/7/2017 | Male | 60 |
| Y4 | Yazd | 8/13/2017 | Female | 45 |
| Y5 | Yazd | 8/24/2017 | Male | 19 |
| Y6 | Yazd | 9/25/2017 | Male | 21 |
Antibiotic susceptibility testing
Kirby-Bauer disk diffusion method was employed in accordance with the guidelines promulgated by the Clinical and Laboratory Standards Institute (19). For this purpose, all of the S. Enteritidis strains were screened for resistance to different antibiotics, including amoxicillin (20 μg), cefepime (30 μg), cefotaxime (30 μg), ceftazidime (30 μg), ceftriaxone (30 μg), cefuroxime (30 μg), ciprofloxacin (5 μg), chloramphenicol (30 μg), imipenem (10 μg), meropenem (10 μg), streptomycin (10 μg), tetracycline (30 μg), and trimethoprim/sulfamethoxazole (25 μg). In brief, bacterial suspensions taken from fresh overnight cultures were adjusted to 0.5 McFarland standard and then streaked onto MHA plates. Subsequently, antibiotic disks were placed on each plate. After incubation of MHA plates at 37 °C for 20–24 hr, the zone of growth inhibition surrounding the antibiotic disk was measured. S. Enteritidis showing intermediate resistance to antibiotics were considered resistant. MDR was defined as non-susceptibility to at least one antimicrobial agent in three or more antimicrobial categories (20). In all assays, Escherichia coli ATCC 25922 was used as quality control in order to ensure the accuracy of susceptibility testing (21).
Detection of virulence genes
Total DNA from S. Enteritidis strains was extracted by boiling method (22). For this purpose, bacterial strains were harvested from MHA plates, suspended in 200 µl of double-distilled water, and incubated at 100 °C for 15 min. The suspensions were centrifuged at 8000 g for 10 min, after which the supernatant was transferred to another microfuge tube and exploited for subsequent PCR reactions. The primer sequences used for amplification of virulence genes, predicted amplicon sizes, and PCR annealing temperatures of the amplified products are listed in Table 2. Using an Eppendorf thermal cycler (Eppendorf, Germany), extracted DNA (2 μl) was amplified in a 25-μl reaction volume containing 10×PCR buffer (500 mM KCl, 0.8% Nonidet P40, 100 mM Tris–HCl, pH 8.8), 2.5 mM MgCl2, 200 μM of deoxynucleotide triphosphates, forward and reverse primers (0.25 μM each), and 1 U of Taq DNA polymerase. After an initial denaturation at 95 °C for 5 min, the cycling conditions were 30 cycles of denaturation at 94 °C for 30 sec, annealing at different temperatures (Table 2) for 30 sec, extension at 72 °C for 1 min, and a 2-min final extension at 72 °C. The PCR products (10 μl) were loaded on a 1.5% (w/v) ultrapure agarose gel stained with SYBR Safe DNA Gel Stain (Invitrogen, Thermo Fisher Scientific, USA). It was then subjected to electrophoresis in 1×TBE buffer (0.089 M Tris-borate, 0.002 M EDTA; pH 8.0) at 100 V for 40 min. Finally, the gel was visualized with a Gel Doc 2000 gel documentation system (Bio-Rad Laboratories, Hercules, CA, USA).
Table 2.
Primers used in the present study for virulence genotyping
| Gene | Primer sequences (5ˊ to 3ˊ) | S (bp) | Ann (°C) | Reference |
|---|---|---|---|---|
| invA | F-ACAGTGCTCGTTTACGACCTGAAT R-AGACGACTGGTACTGATCGATAAT |
243 | 60 | (23) |
| hilA | F-CGTGAAGGGATTATCGCAGT R-GTCCGGGAATACATCTGAGC |
296 | 56 | (24) |
| spvC | F-ACTCCTTGCACAACCAAATGCGGA R-TGTCTCTGCATTTCGCCACCATCA |
571 | 56 | (23) |
| sipA | F-CCATTCGACTAACAGCAGCA R-CGGTCGTACCGGCTTTATTA |
449 | 56 | (24) |
| sopE | F-CGAGTAAAGACCCCGCATAC R-GAGTCGGCATAGCACACTCA |
362 | 58 | (25) |
| stn | F-TTGTCTCGCTATCACTGGCAACC R-ATTCGTAACCCGCTCTCGTCC |
617 | 59 | (26) |
| pefA | F-TTGCACTGGGTGGTTCTGG R-TGTAACCCACTGCGAAAG |
485 | 56 | (27) |
| rck | F-AACGGACGGAACACAGAGTC R-TGTCCTGACGAAAGTGCATC |
189 | 59 | (25) |
| sipC | F-AGACAGCTTCGCAATCCGTT R-ATTCATCCCTTCGCGCATCA |
446 | 61 | (24) |
| ssaR | F-GTTCGGATTTGCTTCGG R-TCTCCAGTGACTAACCCTAACCAA |
1628 | 59 | (28) |
| ssrA | F-CTTACGATTACGCCATTTACGG R-ATTTGGTGGAGCTGGCGGGAGT |
706 | 58 | (29) |
| sopB | F-CCTCAAGACTCAAGATG R-TACGCAGGAGTAAATCGGTG |
1987 | 56 | (30) |
| sefA | F-GCAGCGGTTACTATTGCAGC R-TGTGACAGGGACATTTAGCG |
321 | 55 | (31) |
| sopE2 | F-TCAGGTGGAGCTGTGGA R-TCCAAAAACAGGAAACCACAC |
642 | 56 | (32) |
S: Size of PCR amplicons; Ann: Annealing temperature
DNA sequencing
One representative of each virulence gene was directly sequenced (Macrogen Research, Seoul, Korea). The corresponding DNA sequences were analyzed online by BLAST software (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Moreover, the DNA sequences were submitted to the EMBL/GenBank databases. S. Enteritidis ATCC13076 was used as the control.
Pulsed-field gel electrophoresis
All of the S. Enteritidis strains were typed by PFGE. Digestion was performed with the restriction enzyme XbaI. The resultant restriction fragments were separated with a CHEF-DR III Chiller apparatus (Bio-Rad Laboratories, Hercules, CA, USA) on 1.0% agarose gels (PFGE certified; Bio-Rad) as described previously (33). GelCompare II software version 6.6 (Applied Maths, Austin TX) was also used to examine the patterns. In addition, clustering was performed based upon the unweighted pair group average method (UPGMA) on a Dice coefficient.
Results
In total, 59 Salmonella strains were successfully isolated from 2116 stool samples, which were collected from patients with gastroenteritis in various Iranian cities (including Hamedan, Karaj, Semnan, and Yazd) from April to September 2017. The most prevalent serotype was Enteritidis, accounting for 45.8% (n = 27) of all Salmonella strains, followed by Paratyphi C (n = 12, 20.3%), Typhimurium (n = 11, 18.6%), Paratyphi B (n = 7, 11.9%), and Paratyphi A (n = 2, 3.4%). Out of all 59 patients (n = 27), 14 (51.9%) and 13 (48.1%) were males and females, respectively, with ages ranging from 2 to 71 years old (Table 1).
Among 27 S. Enteritidis strains, 4 MDR strains (14.8%) were detected. We also observed 9 distinct antibiotypes (Table 3), among which Ab4 (simultaneously resistant to ciprofloxacin and cefuroxime) was ranked the most frequent resistance type, followed by Ab8 (only resistant to cefuroxime). Remarkably, almost three-fourths of the strains were resistant to ciprofloxacin (Figure 2). By contrast, resistance towards cefepime, ceftazidime, ceftriaxone, and trimethoprim/sulfamethoxazole was observed less frequently. Cefotaxime, chloramphenicol, imipenem, meropenem, and tetracycline were the antibiotics to which all strains were entirely susceptible. Additionally, 4 strains (14.8%) were found to be sensitive to all 13 tested antibiotics (Table 3).
Table 3.
Antimicrobial resistance profiles among 27 Salmonella enterica serotype Enteritidis strains
| Antibiotype | Antimicrobial resistance pattern | n (%) |
|---|---|---|
| Ab1 | CIP-CXM-STR-AMX-FEP-CAZ-CRO | 1 (3.7) |
| Ab2 | CIP-CXM-STR-TET | 1 (3.7) |
| Ab3 | CIP-CXM-STR | 2 (7.4) |
| Ab4 | CIP-CXM | 8 (29.6) |
| Ab5 | CXM-AMX | 1 (3.7) |
| Ab6 | STR-AMX | 2 (7.4) |
| Ab7 | CIP | 1 (3.7) |
| Ab8 | CXM | 7 (25.9) |
| Ab9 | Sensitive to all tested antibiotics | 4 (14.8) |
AMX: amoxicillin; CAZ: ceftazidime; CIP: ciprofloxacin; CRO: ceftriaxone; CXM: cefuroxime; FEP: cefepime; STR: streptomycin; TET: tetracycline
Figure 2.
Prevalence of antibiotic resistance in Salmonella enterica serotype Enteritidis strains. The bar charts related to cefotaxime, chloramphenicol, imipenem, meropenem, and tetracycline (to which the strains were completely susceptible) are not depicted

AMX: amoxicillin; CAZ: ceftazidime; CIP: ciprofloxacin; CRO: ceftriaxone; CXM: cefuroxime; FEP: cefepime; STR: Streptomycin; TET: tetracycline
With regard to virulence genes, all strains possessed invA, hilA, sefA, sipA, sopB, and sopE2 (Figure 3). Other virulence genes including stn, ssrA, ssaR, sipC, and sopE were each found in 92.6% of strains (n = 25). The least prevalent virulence gene was rck (n = 6; 22.2%). The assigned GenBank accession numbers for virulence genes are KY934465 (pefA), KY934468 (sopB), KY942079 (sopE), KY942080 (sopE2), KY942081 (invA), KY942082 (ssaR), MF004269 (ssrA), MF004268 (hilA), MF004270 (stn), MF033537 (spvC), KY934466 (sipC), and KY934467 (rck).
Figure 3.
Virulence profiles (virulotypes) of 27 Salmonella enterica serotype Enteritidis strains. Green and red squares represent the presence and absence of virulence genes, respectively
Based on combinations of virulence genes, 12 virulence profiles (virulotypes) were detected among the strains. As evidenced in Figure 3, VP2 (harboring all genes except for rck) was the most common virulotype, occurring in 44.4% of the S. Enteritidis strains (n = 12).
PFGE analysis revealed that all of the S. Enteritidis strains were divided into two distinct pulsotypes (94% genetic similarity), as illustrated in Figure 4. In this context, the majority of the strains belonged to pulsotype B (n = 21), while cluster A contained only 6 strains. The distribution of antibiotypes, virulence profiles, and geographic location of the strains were also compared with that of pulsotypes (Table 4). For instance, pulsotype B comprised strains obtained from all four cities, while no strains from Karaj were observed within pulsotype A. Moreover, all of the Ab8 strains except one shared the same pulsotype. Interestingly, each pulsotype exhibited completely different virulotypes. Of note, VP4 (harboring all genes except rck and spvC) was only presented in pulsotype A, whereas VP2 was confined to pulsotype B.
Figure 4.
The unweighted pair-group method with arithmetic mean (UPGMA) dendrogram indicates the genetic relatedness among Salmonella enterica serotype Enteritidis strains based upon pulsed-field gel electrophoresis fingerprints
Table 4.
Distribution of different antibiotypes and virulotypes among Salmonella enterica serotype Enteritidis pulsotypes
| Pulsotype | City (n) | Antibiotype (n) | Virulotype (n) |
|---|---|---|---|
| A | Hamedan (4), Karaj (0), Semnan (1), and Yazd (1) | Ab2 (1), Ab4 (4), and Ab8 (1) | VP4 (3), VP6 (1), VP8 (1), and VP 11 (1) |
| B | Hamedan (4), Karaj (6), Semnan (6), and Yazd (5) | Ab1 (1), Ab3 (2), Ab4 (4), Ab5 (1), Ab6 (2), Ab7 (1), Ab8 (6), and Ab9 (4) | VP1 (2), VP2 (12), VP3 (2), VP5 (1), VP7 (1), VP9 (1), VP10 (1), and VP12 (1) |
Discussion
As a neglected pathogen, Salmonella still remains one of the most frequent causative agents of foodborne illnesses throughout the world, representing a substantial economic burden in both developing and high-income countries. According to the Global Burden of Disease Study, an estimated 95 million cases of Salmonella enterocolitis occurred in 2017, resulting in more than 50,000 deaths (34). NTS serovars, especially S. Typhimurium and S. Enteritidis, are responsible for the majority of human salmonellosis cases in Asian, African, European, and North American countries (35). Contaminated foods of animal origin are primary transmission vehicles, though other routes, including person-to-person contact, animal contact, and even environmental exposure may account for a minor fraction of salmonellosis (36). Notwithstanding several epidemiological studies on the prevalence of S. Enteritidis in various food samples in Iran (33,37,38), insofar as we know, there is a paucity of published data on the occurrence, antibiotic resistance patterns, and virulence gene profiles of clinical strains in different regions of our country.
In the course of the past decades, antimicrobial resistance has emerged as an eminent global public health issue (8). This study revealed that 14.8% of S. Enteritidis strains were resistant to three or more antibiotics. These strains belonged to Ab1 (n = 1, 3.7%), Ab2 (n = 1, 3.7%), and Ab3 (n = 2, 7.4%). The predominant antibiotype was Ab4 (simultaneously resistant to ciprofloxacin and cefuroxime), which accounted for 29.6% of the strains. Cephalosporins and fluoroquinolones are among the therapeutic regimens recommended by clinicians against salmonellosis in humans. Owing to its broad-spectrum activity, fluoroquinolones have become a mainstay for treating severe Salmonella infections (39). In the current survey, a marked resistance (48.2%) was noted against ciprofloxacin, which is higher than the rates reported in several studies from Saudi Arabia (40), Greece (41), China (42), the USA (43), and Italy (25). A previous study conducted in Tehran, Iran, reported a nearly negligible resistance rate towards ciprofloxacin (13). However, a later investigation from the same city demonstrated a steep rise in the occurrence of S. Enteritidis strains that were not sensitive to ciprofloxacin (14). These results may be attributable to the extensive utilization of quinolones in animal husbandry and farm poultry, resulting in the development and dissemination of quinolone-resistant Salmonella strains (44). Consistent with our findings, a high frequency of resistance against cefuroxime (a second-generation cephalosporin) was observed in some recent studies (14, 40, 45). In the current study, a large proportion of S. Enteritidis strains still remains susceptible to third- and fourth-generation cephalosporins (i.e., ceftazidime, cefotaxime, ceftriaxone, and cefepime), which corroborates the findings of several investigations from other countries including Saudi Arabia (40), Greece (41), and Brazil (46). However, two previous works from China (42) and Iran (14) reported higher rates of resistance against the newer generations of cephalosporins.
Aminoglycosides have been usually used as growth promoters in animals, though these agents are not recommended for treating salmonellosis (47). In the present work, 22.2% of S. Enteritidis strains were resistant to streptomycin. Contrary to our findings, other surveys showed a much greater occurrence of aminoglycoside resistance (13, 14, 40, 42). Nevertheless, two investigations from Brazil (46) and the USA (43) demonstrated very low rates of streptomycin resistance among clinical S. Enteritidis. We also found that all of the strains except one were susceptible to trimethoprim-sulfamethoxazole, which is higher than those reported by other studies (13, 14, 40).
Even though carbapenem resistance is being increasingly reported in Enterobacteriaceae, it is still extremely rare in Salmonella (48). Carbapenems are generally administered as a last resort for treating MDR Gram-negative bacterial infections (48). Fortunately, all the strains were susceptible to imipenem and meropenem in the present study, indicating that these drugs are potentially effective for the treatment of complicated and severe cases of salmonellosis.
The existence of virulence genes has been demonstrated to be robustly associated with Salmonella pathogenicity (5). In the present study, all strains (100%) were positive for invA, hilA, sefA, sipA, sopB, and sopE2, indicating that these genes are widespread among clinical S. Enteritidis strains. Similar to our findings, previous studies confirmed the presence of invA in all strains of S. Enteritidis (18, 43, 46, 49, 50). The InvA protein is essential for gut epithelial invasion and its gene sequence is specific to the genus Salmonella. HilA, an OmpR/ToxR family transcriptional regulator, directly activates the expression of invF and sicA (two SPI-1 genes) which encode SPI-1 T3SS apparatus components (10). It is worthwhile to note that hilA is highly prevalent among S. Enteritidis retrieved from human and food sources (14, 33, 43). As an actin-binding protein, Salmonella invasion protein A (SipA) augments the efficiency of the entry process of the pathogen into host cells by influencing the formation of membrane ruffles and rearrangement of the actin cytoskeleton (10). SipB, SipC, and SipD are translocator proteins that are inserted into host membranes and participate in formation of the SPI-1 T3SS needle complex (10,51). SipC also targets F-actin, which is essential for pathogen internalization and invasion (10). Salmonella outer proteins (Sops) including SopA, SopB, SopD, SopD2, SopE, and SopE2 are effector proteins that are involved in rearrangement of the cytoskeleton as well as playing a crucial role in inducing inflammation and diarrhea (10). Like other SPI-1 genes, the majority of S. Enteritidis strains have been shown to possess genes encoding Sip and Sop proteins (14,46,50).
Interestingly, we found that three plasmid-borne genes (i.e., pefA, spvC, and rck) had the lowest prevalence in comparison with other virulence genes. The plasmid-encoded fimbriae gene (pefA) product facilitates bacterial attachment to host epithelial cells, whereas SpvC, a phosphothreonine lyase, is an effector protein that is involved in immune evasion in the early stages of infection as well as dissemination of the pathogen at the later stages (52). Salmonella also invades host cells by a Zipper process mediated by Rck, an outer membrane protein that is involved in the invasion process (53). It is generally believed that virulence plasmids are required for severe gastroenteritis and systemic infections (25). Since all of our clinical strains were obtained from stool samples and not from blood or organs, the low frequency of the above-mentioned genes is justified. On the other hand, the majority of our strains (92.6%) carried the stn gene, which encodes a heat-labile enterotoxin. The presence of the aforementioned gene in Salmonella strains is strongly linked with acute gastroenteritis (54). Previous studies showed that the stn gene is widely distributed in various Salmonella serovars isolated from diverse sources such as humans, beef, and poultry (14, 26, 33, 50, 55).
Thus far, several genotyping methods such as multilocus enzyme electrophoresis, multilocus sequence typing, multiple-locus variable number of tandem repeat analysis, ribotyping, single nucleotide polymorphism-based approaches, and whole-genome sequencing have been proposed as alternatives to PFGE for outbreaks and source tracking investigations (56). Nevertheless, PFGE is still considered the gold standard for Salmonella typing owing to its discriminatory power, reproducibility, ease of execution, and data interpretation (56). In the present study, PFGE analysis revealed that the majority of S. Enteritidis strains showed considerable overlap, which is somewhat consistent with the findings of some previous works from Iran (14, 33, 57). Similarly, data from other countries highlighted the lack of genetic diversity in S. Enteritidis, suggesting that this serotype is highly clonal (58-60). Despite its usefulness, PFGE usually requires being complemented by other typing methods. In other words, the best discrimination could be achieved for these genetically homogeneous pathogens by using a combination of several typing methods.
Conclusion
In summary, this study provides insight into antibiotic resistance patterns, virulence factors, and genetic relatedness of clinical S. Enteritidis isolated from different cities of Iran. The alarmingly high rates of resistance towards ciprofloxacin and cefuroxime necessitate continuous surveillance of local antibiotic resistance among Salmonella strains. The results also showed that the mentioned strains were stemmed from a limited number of clones that had undergone minor genetic changes over time. Future works based upon genetic information, especially whole-genome sequencing, will expand our understanding of S. Enteritidis population diversity.
Acknowledgment
This work was financially supported by grants from Tehran University of Medical Sciences and Health Services (grant number: 29218), Iran.
Authors’ Contributions
Study conception or design: MM SD; Data analyzing and draft manuscript preparation: F F, M M, and H M; Critical revision of the paper: MM SD, M M, H M, and F F; Supervision of the research: MM SD, T ZS, and M D; Final approval of the version to be published: F F, MM SD, T ZS, M D, M M, and H M.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
References
- 1.Majowicz SE, Musto J, Scallan E, Angulo FJ, Kirk M, O’Brien SJ, et al. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis. 2010;50:882–889. doi: 10.1086/650733. [DOI] [PubMed] [Google Scholar]
- 2.Tennant SM, MacLennan CA, Simon R, Martin LB, Imran Khan M. Nontyphoidal salmonella disease: Current status of vaccine research and development. Vaccine. 2016;34:2907–2910. doi: 10.1016/j.vaccine.2016.03.072. [DOI] [PubMed] [Google Scholar]
- 3.Jajere SM. A review of Salmonella enterica with particular focus on the pathogenicity and virulence factors, host specificity and antimicrobial resistance including multidrug resistance. Vet World. 2019;12:504–521. doi: 10.14202/vetworld.2019.504-521. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Kim YJ, Park KH, Park DA, Park J, Bang BW, Lee SS, et al. Guideline for the antibiotic use in acute gastroenteritis. Infect Chemother. 2019;51:217–243. doi: 10.3947/ic.2019.51.2.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Eng SK, Pusparajah P, Ab Mutalib NS, Ser HL, KG Chan, Lee LH. Salmonella: A review on pathogenesis, epidemiology and antibiotic resistance. Front Life Sci. 2015;8:284–293. [Google Scholar]
- 6.Browne AJ, Hamadani BHK, Kumaran EAP, Rao P, Longbottom J, Harriss E, et al. Drug-resistant enteric fever worldwide, 1990 to 2018: a systematic review and meta-analysis. BMC Med. 2020;18:1–33. doi: 10.1186/s12916-019-1443-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Tack B, Vanaenrode J, Verbakel JY, Toelen J, Jacobs J. Invasive non-typhoidal Salmonella infections in sub-Saharan Africa: A systematic review on antimicrobial resistance and treatment. BMC Med. 2020;18:212–245. doi: 10.1186/s12916-020-01652-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.McDermott PF, Zhao S, Tate H. Antimicrobial resistance in nontyphoidal Salmonella. Microbiol Spectr. 2018;4:ARBA. doi: 10.1128/microbiolspec.arba-0014-2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Ramos-Morales F. Impact of Salmonella enterica type III secretion system effectors on the eukaryotic host cell. ISRN Cell Biol. 2012;2012:787934. [Google Scholar]
- 10.Lou L, Zhang P, Piao R, Wang Y. Salmonella pathogenicity island 1 (SPI-1) and its complex regulatory network. Front Cell Infect Microbiol. 2019;9:270. doi: 10.3389/fcimb.2019.00270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Jennings E, Thurston TLM, Holden DW. Salmonella SPI-2 type III secretion system effectors: Molecular mechanisms and physiological consequences. Cell Host Microbe. 2017;22:217–231. doi: 10.1016/j.chom.2017.07.009. [DOI] [PubMed] [Google Scholar]
- 12.Eshraghi S, Soltan Dalall MM, Fardsanei F, Salehi TZ, Ranjbar R, Nikmanesh B, et al. Salmonella enteritidis and antibiotic resistance patterns: a study on 1950 children with diarrhea. Tehran Univ Med J. 2010;12:876–882. [Google Scholar]
- 13.Firoozeh F, Shahcheraghi F, Salehi TZ, Karimi V, Aslani MM. Antimicrobial resistance profile and presence of class I integrongs among Salmonella enterica serovars isolated from human clinical specimens in Tehran, Iran. Iran J Microbiol. 2011;3:112–117. [PMC free article] [PubMed] [Google Scholar]
- 14.Fardsanei F, Soltan Dallal MM, Douraghi M, Memariani H, Bakhshi B, Salehi TZ, et al. Antimicrobial resistance, virulence genes and genetic relatedness of Salmonella enterica serotype Enteritidis isolates recovered from human gastroenteritis in Tehran, Iran. J Glob Antimicrob Resist. 2018;12:220–226. doi: 10.1016/j.jgar.2017.10.005. [DOI] [PubMed] [Google Scholar]
- 15.Soltan Dallal MM, Khalilian M, Masoumi Asl H, Bakhtiari R, Davoodabadi A, Sharifi Yazdi MK, et al. Molecular epidemiology and antimicrobial resistance of Salmonella spp isolated from resident patients in Mazandaran province, northern Iran. J Food Qual Haz Cont. 2016;3:146–151. [Google Scholar]
- 16.Mahmoudi S, Pourakbari B, Moradzadeh M, Eshaghi H, Ramezani A, Ashtiani MTH, et al. Prevalence and antimicrobial susceptibility of Salmonella and Shigella spp among children with gastroenteritis in an Iranian referral hospital. Microb Pathog. 2017;109:45–48. doi: 10.1016/j.micpath.2017.05.023. [DOI] [PubMed] [Google Scholar]
- 17.Procop GW, Church DL, Hall GS, Janda WM, Koneman EW, Schreckenberger PC, et al. Koneman’s color atlas and textbook of diagnostic microbiology. seventh ed. Philadelphia: Wolters Kluwer; 2016. [Google Scholar]
- 18.Fardsanei F, Nikkhahi F, Bakhshi B, Salehi TZ, Asrafi Tamai I, Soltan Dallal MM. Molecular characterization of Salmonella enterica serotype Enteritidis isolates from food and human samples by serotyping, antimicrobial resistance, plasmid profiling, (GTG)5-PCR and ERIC-PCR. New Microbes New Infect. 2016;14:24–30. doi: 10.1016/j.nmni.2016.07.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.CLSI. M100 Performance Standards for Antimicrobial Susceptibility Testing, 29th ed. PA: 2019;Clinical and Laboratory Standards Institute: Wayne; [Google Scholar]
- 20.Raman G, Avendano EE, Chan J, Merchant S, Puzniak L. Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2018;7:79–102. doi: 10.1186/s13756-018-0370-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Talebreza A, Memariani M, Memariani H, Shirazi MH, Shamsabad PE, Bakhtiari M. Prevalence and antibiotic susceptibility of Shigella species isolated from pediatric patients in Tehran. Arch Pediatr Infect Dis. 2016;4:e32395. [Google Scholar]
- 22.Eshaghi Zadeh SH, Fahimi H, Fardsanei F, Soltan Dallal MM. Antimicrobial resistance and presence of class 1 integrons among different serotypes of Salmonella spp recovered from children with diarrhea in Tehran, Iran. Infect Disord Drug Targets . 2019;19:1–7. doi: 10.2174/1871526519666190130171020. [DOI] [PubMed] [Google Scholar]
- 23.Chiu CH, Ou JT. Rapid identification of Salmonella serovars in feces by specific detection of virulence genes, invA and spvC, by an enrichment broth culture– multiplex PCR combination assay. J Clin Microbiol. 1996;34:2619–2622. doi: 10.1128/jcm.34.10.2619-2622.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Wang YP, Li L, Shen JZ, Yang FJ, Wu YN. Quinolone-resistance in Salmonella is associated with decreased mRNA expression of virulence genes invA and avrA, growth and intracellular invasion and survival. Vet Microbiol. 2009;133:328–334. doi: 10.1016/j.vetmic.2008.07.012. [DOI] [PubMed] [Google Scholar]
- 25.Capuano F, Mancusi A, Capparelli R, Esposito S, Proroga YTR. Characterization of drug resistance and virulotypes of Salmonella strains isolated from food and humans. Foodborne Pathog Dis. 2013;10:963–968. doi: 10.1089/fpd.2013.1511. [DOI] [PubMed] [Google Scholar]
- 26.Prager R, Fruth A, Tschäpe H. Salmonella enterotoxin (stn) gene is prevalent among strains of Salmonella enterica, but not among Salmonella bongori and other Enterobacteriaceae, FEMS Immunol Med Microbiol. 1995;12:47–50. doi: 10.1111/j.1574-695X.1995.tb00173.x. [DOI] [PubMed] [Google Scholar]
- 27.Heithoff DM, Shimp WR, Lau PW, Badie G, Enioutina EY, Daynes RA, et al. Human Salmonella clinical isolates distinct from those of animal origin. Appl Environ Microbiol. 2008;74:1757–1766. doi: 10.1128/AEM.02740-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Hu Q, Coburn B, Deng W, Li Y, Shi X, Lan Q, et al. Salmonella enterica serovar Senftenberg human clinical isolates lacking SPI-1. J Clin Microbiol. 2008;46:1330–1336. doi: 10.1128/JCM.01255-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Kutsukake K, Nakashima H, Tominaga A, Abo T. Two DNA invertases contribute to flagellar phase variation in Salmonella enterica serovar Typhimurium strain LT2. J Bacteriol. 2006;188:950–957. doi: 10.1128/JB.188.3.950-957.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Raffatellu M, Wilson RP, Chessa D, Andrews-Polymenis H, Tran QT, Lawhon S, et al. SipA, SopA, SopB, SopD, and SopE2 contribute to Salmonella enterica serotype Typhimurium invasion of epithelial cells. Infect Immun. 2005;73:146–154. doi: 10.1128/IAI.73.1.146-154.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Mirzaie S, Hassanzadeh M, Ashrafi I. Identification and characterization of Salmonella isolates from captured house sparrows. Turk J Vet Anim Sci. 2010;34:181–186. [Google Scholar]
- 32.Hopkins KL, Threlfall EJ. Frequency and polymorphism of sopE in isolates of Salmonella enterica belonging to the ten most prevalent serotypes in England and Wales. J Med Microbiol, 2004;53:539–543. doi: 10.1099/jmm.0.05510-0. [DOI] [PubMed] [Google Scholar]
- 33.Fardsanei F, Soltan Dallal MM, Douraghi M, Salehi TZ, Mahmoodi M, Memariani H, et al. Genetic diversity and virulence genes of Salmonella enterica subspecies enterica serotype Enteritidis isolated from meats and eggs. Microb Pathog. 2017;107:451–456. doi: 10.1016/j.micpath.2017.04.026. [DOI] [PubMed] [Google Scholar]
- 34.Stanaway JD, Parisi A, Sarkar K, Blacker BF, Reiner RC, Hay SI, et al. The global burden of non-typhoidal Salmonella invasive disease: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Infect Dis. 2019;19:1312–1324. doi: 10.1016/S1473-3099(19)30418-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Arya G, Holtslander R, Robertson J, Yoshida C, Harris J, Parmley J, et al. Epidemiology, pathogenesis, genoserotyping, antimicrobial resistance, and prevention and control of non-typhoidal Salmonella serovars. Curr Clin Micro Rpt. 2017;4:43–53. [Google Scholar]
- 36.de Freitas Neto OC, Penha Filho RAC, Barrow P. Sources of human non-typhoid salmonellosis: a review. Braz J Poultry Sci. 2010;12:1–11. [Google Scholar]
- 37.Soltan Dallal MM, Sharifi Yazdi MK, Mirzaei N, Kalantar E. Prevalence of Salmonella spp in packed and unpacked red meat and chicken in south of Tehran. Jundishapur J Microbiol. 2014;7:e9254. doi: 10.5812/jjm.9254. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Moosavy MH, Esmaeili S, Amiri FB, Mostafavi E, Salehi TZ. Detection of Salmonella spp in commercial eggs in Iran. Iran J Microbiol. 2015;7:50–54. [PMC free article] [PubMed] [Google Scholar]
- 39.Cuypers WL, Jacobs J, Wong V, Klemm EJ, Deborggraeve S, Van Puyvelde S. Fluoroquinolone resistance in Salmonella: Insights by whole-genome sequencing. Microb Genom. 2018;4:e000195. doi: 10.1099/mgen.0.000195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.El-Tayeb MA, Ibrahim ASS, Al-Salamah AA, Almaary KS, Elbadawi YB. Prevalence, serotyping and antimicrobials resistance mechanism of Salmonella enterica isolated from clinical and environmental samples in Saudi Arabia. Braz J Microbiol. 2017;48:499–508. doi: 10.1016/j.bjm.2016.09.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Maraki S, Papadakis IS. Serotypes and antimicrobial resistance of human nontyphoidal isolates of Salmonella enterica from Crete, Greece. Interdiscip Perspect Infect Dis. 2014;2014:256181. doi: 10.1155/2014/256181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Qu M, Lv B, Zhang X, Yan H, Huang Y, Qian H, et al. Prevalence and antibiotic resistance of bacterial pathogens isolated from childhood diarrhea in Beijing, China (2010-2014) Gut Pathog. 2016;8:31–46. doi: 10.1186/s13099-016-0116-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Han J, Gokulan K, Barnette D, Khare S, Rooney AW, Deck J, et al. Evaluation of virulence and antimicrobial resistance in Salmonella enterica serovar Enteritidis isolates from humans and chicken- and egg-associated sources. Foodborne Pathog Dis. 2013;10:1008–1115. doi: 10.1089/fpd.2013.1518. [DOI] [PubMed] [Google Scholar]
- 44.Nair DVT, Venkitanarayanan K, Kollanoor Johny A. Antibiotic-resistant Salmonella in the food supply and the potential role of antibiotic alternatives for control. Foods. 2018;7:167. doi: 10.3390/foods7100167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Aljindan RY, Alkharsah KR. Pattern of increased antimicrobial resistance of Salmonella isolates in the Eastern Province of KSA. J Taibah Univ Med Sci. 2020;15:48–53. doi: 10.1016/j.jtumed.2019.12.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Campioni F, Bergamini AMM, Falcão JP. Genetic diversity, virulence genes and antimicrobial resistance of Salmonella Enteritidis isolated from food and humans over a 24-year period in Brazil. Food Microbiol. 2012;32:254–264. doi: 10.1016/j.fm.2012.06.008. [DOI] [PubMed] [Google Scholar]
- 47.Marshall BM, Levy SB. Food animals and antimicrobials: Impacts on human health. Clin Microbiol Rev. 2011;24:718–733. doi: 10.1128/CMR.00002-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Fernández J, Guerra B, Rodicio MR. Resistance to carbapenems in non-typhoidal Salmonella enterica serovars from humans, animals and food. Vet Sci. 2018;5 doi: 10.3390/vetsci5020040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Retamal P, Fresno M, Dougnac C, Gutierrez S, Gornall V, Vidal R, et al. Genetic and phenotypic evidence of the Salmonella enterica serotype Enteritidis human-animal interface in Chile. Front Microbiol. 2015;6:464–481. doi: 10.3389/fmicb.2015.00464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Zou M, Keelara S, Thakur S. Molecular characterization of Salmonella enterica serotype Enteritidis isolates from humans by antimicrobial resistance, virulence genes, and pulsed-field gel electrophoresis. Foodborne Pathog Dis. 2012;9:232–238. doi: 10.1089/fpd.2011.1012. [DOI] [PubMed] [Google Scholar]
- 51.Myeni SK, Wang L, Zhou D. SipB-SipC complex is essential for translocon formation. PLoS One. 2013;8:e60499. doi: 10.1371/journal.pone.0060499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Haneda T, Ishii Y, Shimizu H, Ohshima K, Iida N, Danbara H. Salmonella type III effector SpvC, a phosphothreonine lyase, contributes to reduction in inflammatory response during intestinal phase of infection. Cell Microbiol. 2012;14:485–499. doi: 10.1111/j.1462-5822.2011.01733.x. [DOI] [PubMed] [Google Scholar]
- 53.Mambu J, Virlogeux-Payant I, Holbert S, Grépinet O, Velge P, Wiedemann A. An updated view on the Rck Invasin of Salmonella: still much to discover. Front Cell Infect Microbiol. 2017;7:500. doi: 10.3389/fcimb.2017.00500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Chopra AK, Huang JH, Xu XJ, Burden K, Niesel DW, Rosenbaum MW. Role of Salmonella enterotoxin in overall virulence of the organism. Microb Pathog. 1999;27:155–171. doi: 10.1006/mpat.1999.0294. [DOI] [PubMed] [Google Scholar]
- 55.Deguenon E, Dougnon V, Lozes E, Maman N, Agbankpe J, Abdel-Massih RM, et al. Resistance and virulence determinants of faecal Salmonella spp isolated from slaughter animals in Benin. BMC Res Notes. 2019;12:317–329. doi: 10.1186/s13104-019-4341-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Wattiau P, Boland C, Bertrand S. Methodologies for Salmonella enterica subsp enterica subtyping: Gold standards and alternatives. Appl Environ Microbiol. 2011;77:7877–7885. doi: 10.1128/AEM.05527-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Rahmani M, Peighambari SM, Svendsen CA, Cavaco LM, Agersø Y, Hendriksen RS. Molecular clonality and antimicrobial resistance in Salmonella enterica serovars Enteritidis and Infantis from broilers in three Northern regions of Iran. BMC Vet Res. 2013;9:66–81. doi: 10.1186/1746-6148-9-66. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Dudek B, Książczyk M, Krzyżewska E, Rogala K, Kuczkowski M, Woźniak-Biel A, et al. Comparison of the phylogenetic analysis of PFGE profiles and the characteristic of virulence genes in clinical and reptile associated Salmonella strains. BMC Vet Res. 2019;15:312–333. doi: 10.1186/s12917-019-2019-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Son I, Zheng J, Keys CE, Zhao S, Meng J, Brown EW. Analysis of pulsed field gel electrophoresis profiles using multiple enzymes for predicting potential source reservoirs for strains of Salmonella enteritidis and Salmonella typhimurium isolated from humans. Infect Genet Evol. 2013;16:226–233. doi: 10.1016/j.meegid.2013.01.020. [DOI] [PubMed] [Google Scholar]
- 60.Ziebell K, Chui L, King R, Johnson S, Boerlin P, Johnson RP. Subtyping of Canadian isolates of Salmonella Enteritidis using multiple locus variable number tandem repeat analysis (MLVA) alone and in combination with pulsed-field gel electrophoresis (PFGE) and phage typing. J Microbiol Methods. 2017;139:29–36. doi: 10.1016/j.mimet.2017.04.012. [DOI] [PubMed] [Google Scholar]



